BackOrganon Overview
Organon & Co.

Organon Target Price

Analysts' average 12-month price target for Organon is $14.

Get informed when a big investor buys or sells

+ Follow

Share Price

$13.68

Average Target Price

$14.002.3% upside

1 analysts in the last 4 months

High: $14 | Low: $14

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-04-27Piper Sandler$142.3% upsideOpen
2026-04-10BNP Paribas$1212.3% downsideOpen
2026-02-24Barclays$841.5% downsideOpen
2025-12-08Barclays$7.545.2% downsideOpen
2025-10-27Piper SandlerDavid Amsellem$563.5% downsideOpen
2025-05-15Piper SandlerDavid Amsellem$1831.6% upsideOpen
2025-05-05Morgan StanleyTerence Flynn$1026.9% downsideOpen
2024-04-29Piper SandlerDavid Amsellem$2475.4% upsideOpen
2023-06-26Piper SandlerDavid Amsellem$34148.5% upsideOpen

Organon (OGN) FAQ

Organon's target price stands at $14. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $14 for OGN implies 2.3% upside versus today's price ($13.68). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how Organon's target price evolved across reporting periods, while the comparison chart places OGN next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, target price is commonly used to spot outliers. Organon's reading of $14 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.